Influvac
TA / DEDIČSTVO
Influvac už viac ako 70 rokov pomáha chrániť komunity pred chrípkou. Pomohlo im to zabrániť tomu, aby premeškali chvíle, ktoré si cenia (1-3)

Použitá literatúra:
- Van de Witte SV, Nauta J, Giezeman-Smits KM, et.Trivalent inactivated subunit influenza vaccine Influvac.30-year experience of safety and immunogenicity. Trials in Vaccinology. 2012;42-48;
- Van de Witte SV, Nauta J, Montomoli E, Weckx J. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessingnoth anti-haemagglutinin and virus neutralisation antibody responses. Vaccine 2018;36(40):6030-6038;
- Vesikari T, et al.Immunogenicity nad safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized study. IJID.2020; 92:29-37.